Polymorphisms in the XPC gene affect urinary bladder cancer risk: a case-control study, meta-analyses and trial sequential analyses
Open Access
- 1 June 2016
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 27018
Abstract
Compromised activity of the DNA repair enzymes may raise the risk of a number of cancers. We analyzed polymorphisms in the Xeroderma Pigmentosum, Complementation Group C (XPC) gene for their correlation with urinary bladder cancer. Ala499Val and Lys939Gln polymorphisms were genotyped in 234 urinary bladder cancer cases and 258 control samples. A significant association between Ala499Val polymorphism and bladder cancer was observed (OR = 1.78, CI = 1.19–2.66, p = 0.005); however, Lys939Gln was unrelated (OR = 0.97, CI = 0.65–1.45, P = 0.89). Further analysis revealed that Ala499Val was a significant risk factor only in the presence of smoking (OR = 2.23, CI = 1.28–3.87, p < 0.004) or tobacco chewing (OR = 2.40, CI = 1.43–4.04, p = 0.0008). To further appraise the association, we undertook meta-analyses on seven studies (2893 cases and 3056 controls) on Ala499Val polymorphism and eleven studies (5064 cases and 5208 controls) on Lys939Gln polymorphism. Meta-analyses corroborated the above results, showing strong association of Ala499Val (OR = 1.54, CI = 1.21–1.97, p = 0.001) but not that of Lys939Gln (OR = 1.13, CI = 0.95–1.34, p = 0.171) with urinary bladder cancer risk. In conclusion, XPC Ala499Val substitution increases urinary bladder cancer risk, but Lys939Gln appears to be neutral.Keywords
This publication has 29 references indexed in Scilit:
- XPC gene polymorphisms contribute to bladder cancer susceptibility: a meta-analysisTumor Biology, 2013
- Associations of Lys939Gln and Ala499Val polymorphisms of theXPCgene with cancer susceptibility: A meta-analysisInternational Journal of Cancer, 2013
- Interaction between Polymorphisms of DNA Repair Genes Significantly Modulated Bladder Cancer RiskInternational Journal of Medical Sciences, 2012
- XPC Lys939Gln polymorphism is associated with the decreased response to platinum based chemotherapy in advanced non-small-cell lung cancer.2010
- Estimating required information size by quantifying diversity in random-effects model meta-analysesBMC Medical Research Methodology, 2009
- Attenuated Expression of Xeroderma Pigmentosum Group C Is Associated with Critical Events in Human Bladder Cancer Carcinogenesis and ProgressionCancer Research, 2007
- Polymorphisms inXPD,XPCand the risk of death in patients with urinary bladder neoplasmsActa Oncologica, 2007
- Comprehensive Analysis of 22XPCPolymorphisms and Bladder Cancer RiskCancer Epidemiology, Biomarkers & Prevention, 2006
- Genotypes, haplotypes and diplotypes of XPC and risk of bladder cancerCarcinogenesis, 2006
- Constitutional short telomeres are strong genetic susceptibility markers for bladder cancerCarcinogenesis, 2005